01
Apr
Results Update – Virtual Tumour
Comments
Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that positive results have been generated in a pre-clinical in-vivo study into breast cancer based on the Company’s “Virtual Tumour” model predictions. The directors believe these results provide further validation as to the predictive capability of the Company’s technology.